Clinical trials sponsored by Sixth Affiliated Hospital, Sun Yat-sen University

Phase breakdown

Conditions studied

Recruiting trials led by Sixth Affiliated Hospital, Sun Yat-sen University

• A Retrospective Analysis of Robot-Assisted Versus Endoscopic Breast-Conserving Surgery for Breast Cancer
  NCT07321145 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: Female · 1 location
• Adjuvant Chemotherapy Combined With Targeted Therapy or Not in the T3-4N2 Colorectal Cancer Patients
  NCT05797467 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Adjuvant Chemotherapy in Clinical Local Advanced CRC Following Preoperational Therapies and pT0-3N0M0 Diagnosis
  NCT03748485 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Application of Amide Proton Transfer-Weighted Imaging in Predicting Pathological Complete Response After Neoadjuvant Therapy of Rectal Cancer
  NCT06719414 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 2 locations
• Clinical Trial of Neoadjuvant mFOLFOX Plus Alvenor for LARC Patients With High YWHAB Expression
  NCT07176182 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Comparison of Postoperative Anal Function Between Parks and Bacon Techniques in Low Rectal Cancer
  NCT05943444 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Comprehensive Analysis of Gut Microbiota Signatures in Metastatic Colorectal Cancer
  NCT07154173 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Efficacy and Safety of Dual-targeted Therapy With Upadacitinib and Ustekinumab Versus Intensified Ustekinumab Therapy in Crohn's Disease
  NCT06520397 · Phase: Phase 4 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Efficacy and Safety of Upatinib in the Treatment of Active Anal Fistulas in Crohn's Disease
  NCT06902987 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Efficacy and Safety of Vedolizumab Combined With Upadacitinib in Patients With Ulcerative Colitis
  NCT06095596 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Exclusive Enteral Nutrition Therapy for Active and Complicated Crohn's Disease
  NCT07504510 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• IBD Biomarker Discovery and Validation Platform
  NCT07686406 · Phase: Not specified · Ages: 14 Years and older · Sex: All (male and female) · 4 locations
• Interleukin-23 Monoclonal Antibody for Inflammatory Bowel Disease: Efficacy and Safety
  NCT07216014 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 2 locations
• Mesenteric Surgical Margin for Crohn's Disease Endoscopic Recurrence
  NCT06241170 · Phase: Not applicable (e.g. observational or device study) · Ages: 14 Years to 65 Years · Sex: All (male and female) · 1 location
• Modified Long-Course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor for MSS/pMMR High-risk Mid/Low LARC (MODIFI-RC-I)
  NCT06923345 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Node-Sparing Low-Dose Radiotherapy Concurrent With Chemotherapy and PD-1 Inhibitor in pMMR/MSS High-Risk Locally Advanced Colon Cancer: A Prospective, Single-Arm, Phase II Trial
  NCT07279077 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Node-Sparing Short-Course Radiotherapy Plus Chemotherapy, Bevacizumab and PD-1 Inhibitor in Metastatic pMMR/MSS Colorectal Cancer (MODIFI-CRC)
  NCT06958419 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Node-Sparing Short-Course Radiotherapy Sequential Chemotherapy and PD-1 Inhibitor for Mid/Low pMMR/MSS Rectal Cancer (MODIFI-RC-II)
  NCT06958432 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Predicting the Efficacy of Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer Using an AI Platform Based on Multi-parametric MRI
  NCT05523245 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Preoperative Oral Midazolam to Postoperative Pain Relief in Sleep Disturbance or Anxiety Patients With Colorectal Cancer
  NCT06407518 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• Proximally Extended Resection for Rectal Cancer After Neoadjuvant Chemoradiotherapy
  NCT02649647 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Real-World Effectiveness and Safety of Upadacitinib Plus Vedolizumab vs Upadacitinib Monotherapy During Induction in Moderate-to-Severe Ulcerative Colitis
  NCT07442045 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 6 locations
• Real-World Study of IL-23 Inhibitors in Active Crohn's Disease
  NCT07545317 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• SCRT + Chemo Targeted Immuno-neoadjuvant Therapy for High-risk pMMR/MSS RC
  NCT07549399 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• TNFi Plus Low-Dose Upadacitinib vs TNFi Intensification in Crohn's Disease With Suboptimal Response
  NCT07510191 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• The Impact of MTM Model on the Efficacy and Safety of Anticoagulant Therapy in Postoperative Colorectal Cancer Patients
  NCT06998745 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 100 Years · Sex: All (male and female) · 1 location
• Total Mesorectal Excision(TME) With Lateral Lymph Node Dissection Versus TME After Neoadjuvant Chemo-radiotherapy
  NCT03587480 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• ctDNA-guided Adjuvant Chemotherapy in Liver Metastasis of Colorectal Cancer
  NCT05815082 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is Sixth Affiliated Hospital, Sun Yat-sen University recruiting for?

Sixth Affiliated Hospital, Sun Yat-sen University is the lead sponsor of 28 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.